Videos | TCT

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the expo ...

Home October 03, 2018
Home
News | Radiation Dose Management

Image Diagnostics has entered into a product development agreement with ECLS Inc. to design a new radiation shield expected to debut at the 2018 Radiological Society of North America (RSNA) 2018 annual meeting, Nov. 26-30 in Chicago. The radiation shield, conceptualized by ECLS founder James Goldstein, M.D., cardiologist at Royal Oak Michigan’s Beaumont Hospital, is expected to address the adverse health effects of radiation exposure and the strain of long-term wear of protective lead during interventional surgery.

Home October 03, 2018
Home
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon Stertzer, M.D. In this article he shares his views on the current direction and next steps in cardiovascular biomedical technology
Feature

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon ...

Home October 03, 2018
Home
News | Heart Valve Technology

A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and moderate cases of prosthesis-patient mismatch (PPM), meaning the implanted heart valve is too small for the patient, which can lead to inadequate blood flow. The research team from Penn Medicine also found that the risk of death and of heart failure readmissions were 19 percent and 12 percent higher, respectively, after one year as compared to patients without severe PPM.

Home October 03, 2018
Home
News | Hypertension

Two-year results of the Moderato I Study demonstrated immediate, substantial and sustained reduction in blood pressure when BackBeat cardiac neuromodulation therapy (CNT) was used in patients with persistent hypertension (office BP > 150 mmHg). Patients in the study had persistent hypertension despite two or more anti-hypertensive medications and an indication for a pacemaker.

Home October 02, 2018
Home
News | Intra-Vascular Ultrasound (IVUS)

Intravascular ultrasound (IVUS) guidance improved clinical outcomes over angiography guidance during drug-eluting stent (DES) implantation by lowering the rate of target vessel failure at one year in the ULTIMATE trial.

Home October 02, 2018
Home
News | Ultrasound Imaging

October 2, 2018 — GE Healthcare announced an equity investment in SonoSim, which specializes in ultrasound education and ...

Home October 02, 2018
Home
Videos | Womens Cardiovascular Health

Cindy Grines, M.D., chair and professor, department of cardiology, Zucker School of Medicine, Hostra/Northwell, spoke on ...

Home October 01, 2018
Home
Videos | Left Atrial Appendage (LAA) Occluders

Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix ...

Home October 01, 2018
Home
News | Stents Drug Eluting

October 1, 2018 — Recent results from the BIONYX randomized clinical study showed the novel, thin-strutted, polymer ...

Home October 01, 2018
Home
Technology | Stents Drug Eluting

Boston Scientific announced that the U.S. Food and Drug Administration (FDA) has approved its Premarket Approval (PMA) application to market the Eluvia Drug-Eluting Vascular Stent System, specifically developed for the treatment of peripheral artery disease (PAD). The Eluvia stent utilizes a drug-polymer combination to offer sustained release of the drug paclitaxel for a one-year timeframe, designed to prevent tissue regrowth that might otherwise block the stented artery.

Home October 01, 2018
Home
Two of the top videos in September both had to do with interventional cardiology hemodynamic support support protocols. The top piece of content in September is an interview on the protocols used to determine what device technology to use at Henry Ford Hospital in Detroit. Number 13 on the list is another video on late-breaking data presented TCT 2018 from the National Cardiogenic Shock Initiative (NCSI) where mortality was improved by 50 percent over the current standard of care. Pictured here are Abiomed
Feature | Dave Fornell, Editor

October 1, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2018
Home
News | Stents Bioresorbable

New results from the RENASCENT studies presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference showed Amaranth Medical’s Magnitude sirolimus-eluting bioresorbable scaffold (BRS) continued to perform well clinically at nine months.

Home October 01, 2018
Home
Videos | Hemodynamic Support Devices

Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts ...

Home October 01, 2018
Home
News | Heart Failure

Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical trial showed a statistically significant reduction in regurgitant volume at one year compared to the control cohort receiving guideline-directed medical therapy. Results of the REDUCE FMR trial were presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21-25 in San Diego.

Home September 28, 2018
Home
Subscribe Now